Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

THE ONCOLOGY INSTITUTE, INC.

(TOI)
  Report
Real-time Estimate Cboe BZX  -  01:31 2022-11-29 pm EST
1.440 USD   +2.13%
11/22The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa
GL
11/22The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa
AQ
11/22The Oncology Institute, Inc. Adds Roberto Ochoa as Senior Medical Director for Florida
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds

Oncology Institute Enrolls First Two Patients in US in Late-Stage Cancer Treatment Trial

09/29/2022 | 10:24am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ELI LILLY AND COMPANY -1.07% 361.84 Delayed Quote.32.23%
THE ONCOLOGY INSTITUTE, INC. -7.24% 1.41 End-of-day quote.-85.54%
All news about THE ONCOLOGY INSTITUTE, INC.
11/22The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader D..
GL
11/22The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader D..
AQ
11/22The Oncology Institute, Inc. Adds Roberto Ochoa as Senior Medical Director for Florida
CI
11/22The Oncology Institute, Inc. acquired The South Miami Clinic.
CI
11/15Oncology Institute, Inc. : Results of Operations and Financial Condition, Regulation FD Di..
AQ
11/11Guggenheim Adjusts Price Target on The Oncology Institute to $6 From $7, Maintains Buy ..
MT
11/09Transcript : The Oncology Institute, Inc., Q3 2022 Earnings Call, Nov 09, 202..
CI
11/09ONCOLOGY INSTITUTE, INC. Management's Discussion and Analysis of Financial Condition a..
AQ
11/09The Oncology Institute, Inc. Reports Earnings Results for the Third Quarter and Nine Mo..
CI
11/09The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Ye..
GL
More news
Analyst Recommendations on THE ONCOLOGY INSTITUTE, INC.
More recommendations
Financials (USD)
Sales 2022 246 M - -
Net income 2022 -11,4 M - -
Net cash 2022 56,0 M - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 102 M 102 M -
EV / Sales 2022 0,19x
EV / Sales 2023 0,37x
Nbr of Employees 658
Free-Float 76,9%
Chart THE ONCOLOGY INSTITUTE, INC.
Duration : Period :
The Oncology Institute, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,41 $
Average target price 6,00 $
Spread / Average Target 326%
EPS Revisions
Managers and Directors
Bradford D. Hively Chief Executive Officer & Director
Daniel Virnich President
Mihir Shah Chief Financial Officer
Yale Podnos Chief Medical Officer
G. Philip Reger Chief Information Officer